Sernova Agrees on Terms to Gain Access to Proprietary Stem Cell...

Sernova and UHN have entered into a Term Sheet with an exclusive negotiation period which outlines the terms of the definitive license agreement for the granting of an exclusive license to Sernova covering all patent rights relating to the UHN stem cell technologies including for the treatment of diabetes.

http://ift.tt/1krW5UM